Gene · 10148
Papers1,901
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,901
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of calcium metabolism related score associated with the poor outcome in papillary thyroid carcinoma. | Front Oncol | 2023 | 37056339 | PubTator, text mining | PubMed |
| Ubiquitin-Specific Protease 43 Impacts Pancreatic Ductal Adenocarcinoma Prognosis by Altering Its Proliferation and Infiltration of Surrounding Immune Cells. | J Immunol Res | 2023 | 37050932 | PubTator, text mining | PubMed |
| Salivary Exosomes in Health and Disease: Future Prospects in the Eye. | Int J Mol Sci | 2023 | 37047335 | PubTator, text mining | PubMed |
| Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. | Int J Mol Sci | 2023 | 37047231 | PubTator, text mining | PubMed |
| Identification and validation of an anoikis-related lncRNA signature to predict prognosis and immune landscape in osteosarcoma. | Front Oncol | 2023 | 37035149 | PubTator, text mining | PubMed |
| Aberrant RNA m6A modification in gastrointestinal malignancies: versatile regulators of cancer hallmarks and novel therapeutic opportunities. | Cell Death Dis | 2023 | 37015927 | PubTator, text mining | PubMed |
| Alterated gene expression in dilated cardiomyopathy after left ventricular assist device support by bioinformatics analysis. | Front Cardiovasc Med | 2023 | 37008310 | PubTator, text mining | PubMed |
| Structural insights into the mechanism of leptin receptor activation. | Nat Commun | 2023 | 37002197 | PubTator, text mining | PubMed |
| Fibrinogen to albumin ratio, a novel serum indicator for evaluating the severity of preeclampsia: A single-center retrospective study. | Medicine (Baltimore) | 2023 | 37000100 | PubTator, text mining | PubMed |
| Human Brain Microvascular Endothelial Cells Exposure to SARS-CoV-2 Leads to Inflammatory Activation through NF-κB Non-Canonical Pathway and Mitochondrial Remodeling. | Viruses | 2023 | 36992454 | PubTator, text mining | PubMed |
| Spatial multiomics map of trophoblast development in early pregnancy. | Nature | 2023 | 36991123 | PubTator, text mining | PubMed |
| IFN-Inducible SerpinA5 Triggers Antiviral Immunity by Regulating STAT1 Phosphorylation and Nuclear Translocation. | Int J Mol Sci | 2023 | 36982532 | PubTator, text mining | PubMed |
| Network-Based Method to Investigate the Promoted Cell Apoptosis Mechanisms of Oridonin in OSCC through the RNA-Transcriptome. | J Immunol Res | 2023 | 36969496 | PubTator, text mining | PubMed |
| Inducible nitric oxide synthase-expressing myeloid-derived suppressor cells regulated by interleukin 35 contribute to the pathogenesis of psoriasis. | Front Immunol | 2023 | 36969174 | PubTator, text mining | PubMed |
| Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation. | Cancer Cell Int | 2023 | 36959615 | PubTator, text mining | PubMed |
| Structural insights into the assembly of gp130 family cytokine signaling complexes. | Sci Adv | 2023 | 36930708 | PubTator, text mining | PubMed |
| Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival. | J Immunother Cancer | 2023 | 36927528 | PubTator, text mining | PubMed |
| JNK/c-Jun pathway activation is essential for HBx-induced IL-35 elevation to promote persistent HBV infection. | J Clin Lab Anal | 2023 | 36916737 | PubTator, text mining | PubMed |
| METTL3-mediated m6A modification of has_circ_0007905 promotes age-related cataract progression through miR-6749-3p/EIF4EBP1. | PeerJ | 2023 | 36908822 | PubTator, text mining | PubMed |
| The Role of m6A Modifications in B-Cell Development and B-Cell-Related Diseases. | Int J Mol Sci | 2023 | 36902149 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10148/papers?page=11